Key result
Supportive measures enable 7 patients with serious cardiac disease to safely undergo ECT without complications.
Why the study?
Therapeutic strategies to prevent cardiac complications during electroconvulsive therapy in patients with serious cardiac disease require clarification.
Does the use of supportive measures (atropinization, oxygenation, pre-medication) prevent cardiac complications in patients with serious cardiac disease undergoing electroconvulsive therapy?
Population
7 patients with serious cardiac disease undergoing electroconvulsive therapy
Comparison
Supportive measures including atropinization, early oxygen inhalations, artificial respiration, mechanical airway, and pre-treatment medications
Design
Case report
Authors
Loading...
Suggests supportive measures may enable safe ECT in cardiac disease; leaves open need for prospective validation.
Case Report (n=7)
Does the use of supportive measures (atropinization, oxygenation, pre-medication) prevent cardiac complications in patients with serious cardiac disease undergoing electroconvulsive therapy?
Patients with serious cardiac disease can safely undergo electroconvulsive therapy when appropriate supportive measures, such as early oxygenation and atropinization, are utilized.
Bankhead et al. (1950) conducted a case report in Cardiac disease undergoing electroconvulsive therapy (n=7). Supportive measures (atropinization, oxygenation, digitalis, quinidine, aminophylline) was evaluated on Safety and successful completion of electroconvulsive therapy. Supportive measures including early oxygenation and atropinization allowed 7 patients with serious cardiac disease to safely undergo electroconvulsive therapy without complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: